Alumis Inc. (ALMS)
NASDAQ: ALMS · Real-Time Price · USD
24.02
-0.73 (-2.95%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Alumis Employees
As of December 31, 2025, Alumis had 224 total employees, including 221 full-time and 3 part-time employees. The number of employees increased by 54 or 31.76% compared to the previous year.
Employees
224
Change (1Y)
54
Growth (1Y)
31.76%
Revenue / Employee
$107,366
Profits / Employee
-$1,086,272
Market Cap
3.06B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 224 | 54 | 31.76% |
| Dec 31, 2024 | 170 | 61 | 55.96% |
| Dec 31, 2023 | 109 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Arcus Biosciences | 601 |
| Beam Therapeutics | 511 |
| Denali Therapeutics | 503 |
| Arcutis Biotherapeutics | 354 |
| Dyne Therapeutics | 258 |
| Structure Therapeutics | 220 |
| Kodiak Sciences | 124 |
| Erasca | 103 |
ALMS News
- 4 weeks ago - Alumis Transcript: Study update - Transcripts
- 4 weeks ago - Alumis' Envudeucitinib Delivers Early and Robust Improvements in Skin Clearance, Quality of Life and Psoriasis Symptoms in Two Phase 3 Trials, Underscoring Its Potential as a Leading Oral Therapy for Plaque Psoriasis - GlobeNewsWire
- 5 weeks ago - Alumis Reports Year End 2025 Financial Results and Highlights Recent Achievements - GlobeNewsWire
- 5 weeks ago - Alumis Announces Late-Breaker Oral Presentation of Phase 3 Data for Envudeucitinib in Moderate-to-Severe Plaque Psoriasis at 2026 American Academy of Dermatology Annual Meeting - GlobeNewsWire
- 7 weeks ago - Alumis Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Alumis to Present at the Leerink Partners Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Alumis Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference - Transcripts
- 2 months ago - Alumis Transcript: Guggenheim Securities Emerging Outlook: Biotech Summit 2026 - Transcripts